Tag: Strides Pharma
Strides Pharma recognized in S&P Global Sustainability Yearbook 2025
This selection places Strides among the top 10 percent globally
Strides Pharma secures approvals for OneSource, India’s first specialty pharma CDMO
Approval from equity shareholders and secured creditors marks a major milestone in the creation of OneSource
Strides records revenue of Rs 40,555 million in FY24, YoY growth...
The company reports highest ever revenue and EBITDA growth up to 77.6%, declares ₹2.5 per share dividend